Cellumen Establishes Collaboration in Breast Cancer Patient Stratification

News

Published: October 4, 2007

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of"Cellumen Establishes Collaboration in Breast Cancer Patient Stratification"

First Name*

Last Name*

Email Address*

Country*

Company Type*

Job Function*

Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out ourPrivacy Policy

Read time:

Cellumen, Inc. and Mayo Foundation for Medical Education and Research announced the formation of a collaboration to apply cellular systems biology (CSB™) profiling to breast cancer patient stratification. The goal is to create a breast cancer patient profile test to improve diagnosis and treatment for individualized medicine.

“We are very pleased to initiate an exciting research and development program with Mayo, a leader in individualized medicine,” stated D. Lansing Taylor, Ph.D, CEO of Cellumen. “We are treating breast tumors as a “system” within the breast cancer patient.

A combination of breast cancer biomarkers and migratory immune cell biomarkers are being multiplexed in tissue micro-array (TMA) samples.

“We are enthusiastic about the synergy between Cellumen and Mayo in approaching this challenging opportunity,” stated Taylor, “Mayo has great expertise and experience that will be applied to this collaboration. Cellumen continues to develop collaborations with the best in class partners to bring CSB solutions to the market.”